About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
The Hepatitis C virus, or HCV, is a devastating viral disease that progresses slowly over time and can cause severe damage to the liver. Historically, HCV was the leading cause of liver cancer and the most common reason for a liver transplant. However, recent scientific advancements have led to a new era of treatments, with cure rates approaching nearly 100%.
Nearly a Decade of Treatment Advances Bring Cures to the Vast Majority of Hepatitis C Patients image
Report
Disease
Nearly a Decade of Treatment Advances Bring Cures to the Vast Majority of Hepatitis C Patients
Nearly a Decade of Treatment Advances Bring Cures to the Vast Majority of Hepatitis C Patients image